News from Veracyte A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

26 Apr, 2017, 08:00 ET Veracyte Announces Multiple Studies Demonstrating Powerful Results from Afirma® Classifiers To Be Presented at the AACE 2017 Annual Meeting

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


19 Apr, 2017, 16:30 ET Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Wednesday, May 3, 2017

Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its first quarter 2017 financial results after close of market on Wednesday, May...


03 Apr, 2017, 12:00 ET Multiple Studies Presented at ENDO 2017 Support Use of Veracyte's Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


23 Mar, 2017, 08:00 ET Veracyte Announces that Multiple Studies Supporting Clinical Utility of Its Afirma® Gene Expression Classifier To Be Presented at ENDO 2017

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


01 Mar, 2017, 16:05 ET Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook

Revenue Grew 31%, to $65.1 Million in 2016 Full-Year Afirma® GEC Volume Increased 20%, to 23,237 Tests Conference Call and Webcast Today at...


28 Feb, 2017, 16:05 ET Veracyte Announces Executive Promotions

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


27 Feb, 2017, 10:20 ET Veracyte Announces Publication of Data Demonstrating Potential for Non-Invasive Nasal Test to Improve Lung Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


21 Feb, 2017, 08:00 ET Veracyte Announces Ten New Blues Plan Coverage Policies for Its Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


15 Feb, 2017, 08:00 ET Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2016 Financial Results on Wednesday, March 1, 2017

Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its fourth quarter and full-year 2016 financial results after close of market on...


08 Feb, 2017, 08:00 ET Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


06 Feb, 2017, 08:00 ET Veracyte Announces Final Medicare Coverage Policies for Percepta® Bronchial Genomic Classifier

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


02 Feb, 2017, 08:00 ET Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman of the board, president and chief executive officer, will present...


13 Dec, 2016, 08:00 ET Veracyte Announces Appointment of Kevin K. Gordon and Other Changes to Its Board of Directors

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


22 Nov, 2016, 07:00 ET Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma® Gene Expression Classifier in 2017

Veracyte, Inc. (NASDAQ: VCYT) announced today that the Centers for Medicare and Medicaid Services (CMS) has released its revised final 2017...


21 Nov, 2016, 08:00 ET Veracyte Appoints Keith Kennedy as Chief Financial Officer

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


15 Nov, 2016, 08:00 ET Veracyte to Participate in Two Upcoming Investor Conferences

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will participate in a fireside chat...


03 Nov, 2016, 16:05 ET Veracyte Announces Third Quarter 2016 Financial Results

Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the third quarter ended September 30, 2016 and provided an update on recent...


02 Nov, 2016, 08:00 ET Veracyte Announces Pricing of Public Offering of 5,000,000 Shares of Common Stock

Veracyte, Inc. (NASDAQ: VCYT) today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public...


01 Nov, 2016, 16:12 ET Veracyte Announces Proposed Public Offering of Common Stock

Veracyte, Inc. (NASDAQ: VCYT) today announced that it has commenced an underwritten public offering of its common stock. All of the shares are...


26 Oct, 2016, 16:30 ET New Data Show that Use of Percepta® Bronchial Genomic Classifier Reduces Surgeries and Other Costly Procedures in Lung Cancer Screening and Diagnosis

Veracyte, Inc. (NASDAQ: VCYT) today announced new data from a prospective, multicenter clinical utility study showing that use of the...


25 Oct, 2016, 08:00 ET Veracyte Announces Launch of Envisia™ Genomic Classifier for Improved Diagnosis of Idiopathic Pulmonary Fibrosis at CHEST Annual Meeting 2016

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


17 Oct, 2016, 17:30 ET Veracyte Releases Preliminary Third Quarter 2016 Financial Results

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


13 Oct, 2016, 08:00 ET Data Demonstrating Clinical Value of Veracyte Genomic Tests for Use in Lung Cancer and IPF to Be Presented at CHEST Annual Meeting 2016

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


30 Sep, 2016, 19:00 ET Veracyte Releases Statement on CMS's Final 2017 Gapfill Rate for the Afirma® Gene Expression Classifier

 Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing diagnostic uncertainty, today issued the statement below...


23 Sep, 2016, 11:45 ET Veracyte Presents Data Demonstrating Potential to Enhance Afirma® Gene Expression Classifier Using an RNA Sequencing Platform

 Veracyte, Inc. (NASDAQ: VCYT) today announced new data suggesting the potential to enhance the performance of the Afirma Gene Expression...